Effect of GLP-1/GLP-1R on the polarization of macrophages in the occurrence and development of atherosclerosis
A phase-Ib study demonstrated a dose-dependent improvement of clinical outcomes, including increase in ON-time duration without dyskinesias and quality of life, dopaminergic medications reduction, and AADC enzymatic activity assessed by PET (Christine et al
Each well was co-transfected with 200 ng of the pGL4.10-ARX promoter construct (WT or 14-bp deletion mutant) and 200 ng of either pcDNA3.1-ATF4-3FLAG or the empty vector using Lipofectamine 2000
Cushing's patients had lower baseline leptin sensitivity, higher fasting insulin, and blunted postprandial GLP-1 secretion compared to BMI-matched controls without cortisol excess
rn *Conclusion* rn IGF-LR3 is a synthetic analog of IGF-1 with potential therapeutic applications in muscle growth and tissue repair
Patients who were on it during trials or through compounding may have priority